Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus - PubMed (original) (raw)
. 1988 Dec;167(2):385-92.
Affiliations
- PMID: 2462306
Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus
D J Petcu et al. Virology. 1988 Dec.
Abstract
Suramin blocked in vitro infection by duck hepatitis B virus, a hepadnavirus, and Rous sarcoma virus, a retrovirus. Although suramin was able to inhibit the virus-encoded reverse transcriptase activities of these two viruses, this inhibition did not appear to account for the anti-viral effect of the drug. In particular, suramin was unable to block synthesis within cells of full-length viral DNAs when added subsequent to infection. The results are consistent with the hypothesis that suramin acted by blocking virus uptake or uncoating. As further support of this hypothesis, we found that suramin also blocked infection by hepatitis delta virus, an RNA virus that is not known to employ reverse transcriptase during the initiation of infection.
Similar articles
- The replication of Rous sarcoma virus is blocked at or before viral DNA synthesis in interferon treated chick embryo fibroblasts.
Strube W, Jungwirth C. Strube W, et al. Eur J Cell Biol. 1985 Nov;39(1):232-5. Eur J Cell Biol. 1985. PMID: 2417844 No abstract available. - Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
Li X, Kuang E, Dai W, Zhou B, Yang F. Li X, et al. Virus Res. 2005 Dec;114(1-2):126-32. doi: 10.1016/j.virusres.2005.06.005. Epub 2005 Jul 27. Virus Res. 2005. PMID: 16054262 - Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes.
Rasshofer R, Choi SS, Wölfl P, Roggendorf M. Rasshofer R, et al. Prog Clin Biol Res. 1991;364:223-34. Prog Clin Biol Res. 1991. PMID: 1826953 No abstract available. - Experimental hepatitis delta virus infection in the animal model.
Ponzetto A, Negro F, Gerin JL, Purcell RH. Ponzetto A, et al. Prog Clin Biol Res. 1991;364:147-57. Prog Clin Biol Res. 1991. PMID: 2020690 Review. No abstract available.
Cited by
- Biographical Feature: William (Bill) S. Mason.
Seeger C. Seeger C. J Virol. 2023 Jan 31;97(1):e0188222. doi: 10.1128/jvi.01882-22. Epub 2023 Jan 9. J Virol. 2023. PMID: 36622221 Free PMC article. No abstract available. - Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q, Chang J, Rijnbrand R, Lam AM, Sofia MJ, Cuconati A, Guo JT. Zhao Q, et al. J Virol. 2022 Dec 21;96(24):e0115022. doi: 10.1128/jvi.01150-22. Epub 2022 Nov 30. J Virol. 2022. PMID: 36448800 Free PMC article. - Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure.
Tsounis EP, Tourkochristou E, Mouzaki A, Triantos C. Tsounis EP, et al. World J Gastroenterol. 2021 Jun 7;27(21):2727-2757. doi: 10.3748/wjg.v27.i21.2727. World J Gastroenterol. 2021. PMID: 34135551 Free PMC article. Review. - Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
Cheng J, Zhao Q, Zhou Y, Tang L, Sheraz M, Chang J, Guo JT. Cheng J, et al. J Virol. 2020 Aug 17;94(17):e00442-20. doi: 10.1128/JVI.00442-20. Print 2020 Aug 17. J Virol. 2020. PMID: 32581092 Free PMC article. - Hepatitis B Virus Entry into Cells.
Herrscher C, Roingeard P, Blanchard E. Herrscher C, et al. Cells. 2020 Jun 18;9(6):1486. doi: 10.3390/cells9061486. Cells. 2020. PMID: 32570893 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials